Dynamic Collaborations for the Development of Immune Checkpoint Blockade Agents

We studied the overview of drug discovery and development to understand the recent trends and potential success factors of interorganizational collaboration by reviewing 1204 transactions performed until 2019 for 107 anticancer drugs approved by the US Food and Drug Administration (FDA) from 1999 to...

Full description

Bibliographic Details
Main Authors: Arisa Djurian, Tomohiro Makino, Yeongjoo Lim, Shintaro Sengoku, Kota Kodama
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/11/6/460